Adora Animal Health Corporation

Company Adora Animal Health Corporation develops animal pharmaceuticals, devices and OTC products as a privately held Kentucky corporation, located in Lexington, Kentucky and Franklin, Tennessee, with a profitable track record since 2010. Two founders are also owners and practicing veterinarians in the world’s foremost equine clinical practice network for thoroughbred horses. Animal Health Industry Sector: Equine and Companion Animals Adora is the drug application sponsor for a branded 1st generation generic injectable equine drug and has proprietary manufacturing processes for making key ingredients and products in the animal joint health and arthritis categories. Primary functions are to slow or stop cartilage degradation within the joint, promote healing and alleviate pain and inflammation. $40MM equine market potential in the US and $200MM internationally.

KeriCure Inc

KeriCure is a cutting edge biotech company that is solving the problem of infection control in the consumer, animal health and medical skin and wound care markets. Application of our nanopolymer technology can provide significant impact on overall healing outcomes and reduce infection rates, saving thousands on medical and veterinary bills. KeriCure's goal is to breathe new life into the stagnant wound care market, where there is expansive market potential and growth capabilities.

Alaria Biotech

Alaria Biotech is a Texas-based startup company working to develop technologies surrounding its implantable drug delivery system, the Everdose. Alaria’s focus is to improve the treatments of critical diseases and disorders through its revolutionary intravenous drug delivery system. Alaria is committed to improving the quality of life for people affected by critical diseases or disorders. Alaria develops technologies and products that relieve patient compliance issues that accompany these diseases. Alaria is currently positioning itself to revolutionize the implantable device market by offering its ​indomitable resolution for advanced drug delivery.

Data Matrix

Data MATRIX process data, analyse it and develop documents to be accepted by the Ministry of Health of Russia, FDA (USA), and EMA. Our products automate the processes of clinical trials; the users manage and monitor its progress online. We adjust and validate our software before the project start and take into account all its aspects to do it the best way. Our team has conducted 158 projects for pharmaceutical and biotech companies and CROs. With Data MATRIX products 6 out of 10 TOP Big Pharma companies reduced their R&D costs by 15%.Our employees are proud to be members of the professional communities, which unite clinical data specialists (CDISC), data managers (ACDM, SCDM), biostatisticians (ISBC), and medical writers (EMWA, AMWA).


Sproutways is Amazon for Genetics, a cannabis market-networks platform with unprecedented access to reliable, high quality genetics to fulfill the needs of commercial and cannabis-aficionado growers while serving the high-growth legal cannabis market. Sproutways has established a central digital platform with comprehensive genetics profiles, grower educational insights, unique custom breeders' diaries, and marketplace data to optimize licensed operators' business practice and allow producers no matter size or location, access to premium-quality, clean and unique genetics for industrial, recreational, and medicinal needs. Genetics has been the key ingredient in the supply chain to dictate and influence the quality, value, and longevity of cannabis plants and their byproducts, from seed to sale. Sproutways has the genetics library exceeding 2,000+ unique cultivars and varieties of landrace, heirloom, and hybrid, from 38 countries with dozens of industry recognition and cup awards.

Knowbella Tech

There is an estimated $14,000,000,000,000.00 of unused intellectual property (IP) in the world. Knowbella Tech captures as much of that as it can, puts it on its Platform, which is not publicly available at https://Platform.Knowbella.Tech. Along with free tools, services, and grants, this IP is provided to science, technology, engineers, and math (STEM) researches and students around the world to push forward that IP. When they collaborate they earn cryptocurrency. One can think of the model as the "AirBnB® of IP" in a "GitHub® for Scientists". The initial business model is capturing that advanced IP and cherry-picking it and selling it companies and governments. This is the Red Hat®/Linux model. A proof of this was done by the Founder in his other company with a publicly traded company for $1.8M USD. With this crowdsourcing model, not only will highly pressing problems solved by making value of unused IP, many additional revenue models emerge. The preseed round was heavily oversubscribed. A lot was accomplished as a result.